Skip to content

To explore safety and performance of Closed Wound Drainage System in Adult & Paediatric subjects in Indian Population.

A prospective, single arm, post market clinical follow-up of Closed Wound Drainage System to explore its safety and performance in Adult & Paediatric subjects in Indian Population. - NIL

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062232
Enrollment
100
Registered
2024-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Romo Vac Set (GS-5002, GS-5002F, GS-5002M, GS-5002S, GS-5002N), Mini Vac Set (GS-5006), Flat Drain Set (GS-5047), Redon Drain Catheter (GS-5004): Device maximum use duration is not more

Sponsors

Romsons Group Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Males and Females Adult & Paediatric who are expected to undergo surgery closed wound drainage procedures 2 The subject who is willing and able to comply with the requirement of the follow-up OR in case of Paediatrics parent of child LAR Legally Acceptable Representative who is willing and able to comply with the requirement of the follow-up. 3 Subject who can provide Informed Consent Form Adult in writing and medically in a position to undergo consent and screening process OR in case of Paediatrics parent of child LAR Legally Acceptable Representative can provide Informed Assent Form Child

Exclusion criteria

Exclusion criteria: 1 Subject who present with medical emergency where treatment is more priority than the informed consent process informed assent process 2 Subject who cannot provide Informed Consent Form Adult such as unconscious mentally challenged subject OR in case of Paediatrics parent of child LAR Legally Acceptable Representative who cannot provide Informed Assent Form Child or give permission etc 3 Any known allergy with any of the material of Closed Wound Drainage System and its components 4 Other conditions which in the opinion of investigators make the patient unsuitable for enrollment or could interfere with his her participation in and completion of the clinical investigation plan protocol 5 Subject who is pregnant or breastfeeding 6 Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital 7 Participation in another research study involving an active investigation within 30 days prior to consent

Design outcomes

Primary

MeasureTime frame
The Primary End Point of the study are as 1 Intended for Closed Wound Drainage 2 Facilitating drainage from the Closed wound site by catheter 3 Angulated sharp tipped trocar needle for easy penetration and placement of drainage catheter 4 Application of optimum negative pressure by flexible bellow jar chamber 5 Facilitating the precise drained volume determination in follow-up from closed wound 6 Improving the quality of life by reduction of symptoms 7 Achieving the intended clinical purposeTimepoint: Device maximum use duration is not more than 7 days

Secondary

MeasureTime frame
The Secondary End Point of the study are as 1 Device material compatibility with the tissue and body fluids 2 Durability Sustainability of device during placement & intended clinical performance 3 Proper fixation fitment of the device accessoriesTimepoint: Device maximum use duration is not more than 7 days

Countries

India

Contacts

Public ContactDr Anoop Batra

Romsons Group Private Limited

cta1@romsons.com9971256314

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026